SciELO - Scientific Electronic Library Online

 
vol.19 issue6Level of knowledge and attitudes about pain in state CAM (Spain) in nursing: degree in nursing and professionalsPercutaneous Epidural lysis of adhesions author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista de la Sociedad Española del Dolor

Print version ISSN 1134-8046

Abstract

TORNERO, C.; HERRERA, J.; MOLA, O.  and  GALVAN, J.. Transdermal Buprenorphine (Feliben®): new therapeutic option for patients with moderate to severe pain. Rev. Soc. Esp. Dolor [online]. 2012, vol.19, n.6, pp.301-309. ISSN 1134-8046.

This paper summarizes the general characteristics of the opioid system and analgesic mechanisms that have allowed the development of new therapeutic options in the therapy areas of moderate to severe pain of both cancer and noncancer origin. It also summarizes the studies forming together the research program and clinical development (phases I and III) of a new pharmaceutical formulation of buprenorphine transdermal patches, Feliben®, which is compared with other formulations of reference in analgesia. Finally, the current opportunity context that these new formulations have in the management of moderate to severe pain is reviewed.

Keywords : Opioids; Buprenorphine transdermal; Feliben®.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License